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AbstrACt
Objectives To translate and culturally adapt an English 
language patient decision aid addressing prostate cancer 
screening, so it can be used by Portuguese men.
Design Qualitative study. We followed the European 
Centre for Disease Prevention and Control’s (ECDC) five- 
step, stakeholder- based approach to adapting health 
communication materials: (1) selection of materials and 
process coordinators, (2) early review, (3) translation and 
back translation, (4) comprehension testing with cognitive 
semi- structured interviews and (5) proofreading. Content 
analysis was performed using Ligre software.
setting and participants Cognitive interviews with 15 
men to refine a decision aid after its translation. Eligible 
participants were Portuguese native- speaking men aged 
55–69 years old recruited from the local community (urban 
and suburban) of Oporto district through advertisements in 
social media and senior universities between January and 
March 2019. A previous diagnosis of prostate cancer was 
the single exclusion criterion.
results Five main themes are presented: informational 
content, information comprehension, sociocultural 
appropriateness, feelings and main message and personal 
perspective concerning prostate cancer screening. Most 
men found the translated version of the decision aid to 
be clear, comprehensive and appropriate for its target 
population, although some suggested that medical 
terms could be a barrier. The data collected from men’s 
interviews afforded the researchers the opportunity to 
clarify concepts and expand existing content.
Conclusions A decision aid was successfully translated 
and adapted to the Portuguese cultural setting. Our ECDC 
based approach can be replicated by other workgroups to 
translate and culturally adapt decision aids.
IntrODuCtIOn
Prostate cancer is the most common cancer 
among men worldwide (1.6 million cases) 
and the seventh leading cause of male cancer 
death, with a total of 366 000 deaths.1 In 
Portugal, there are 90.5 new prostate cancer 
cases yearly per 100 000 inhabitants, making 
it the leading male cancer in terms of inci-
dence. The adjusted mortality rate in 2014 
was 20.3/100,000 with an absolute number of 
1787 deaths from prostate cancer . In 2016 
prostate cancer accounted for 1.7% of all 
deaths.2
Screening for prostate cancer using pros-
tate specific antigen (PSA) test remains 
controversial, implying a trade- off between 
benefits (low mortality reduction, possi-
bility of an early diagnosis) and harms 
(high overdiagnosis and overtreatment with 
the consequent side effects, as well as false 
positive and false negative test results).3–6 
Digital rectal examination (DRE) has not 
been established as a screening test for early 
detection of prostate cancer and no survival 
benefit was found with combined PSA and 
DRE screening.7 8 Many guidelines issued by 
medical organisations support a shared deci-
sion making process, in which decision aids 
may play an important role.9–13 In spite of 
the scientific debate, PSA early detection is 
popular in Portugal. A 2013 population- based 
cross- sectional study showed that 67.3% of the 
Portuguese adult men consider that PSA test 
strengths and limitations of this study
 ► This study led to the development of the first 
Portuguese language decision aid to support 
Portuguese men’s decision concerning prostate 
cancer screening.
 ► With this qualitative design we aimed not solely at 
translating a previously tested English language de-
cision aid, but also at culturally adapting it.
 ► Cognitive interviews allowed for usability and com-
prehensibility testing by engaging end- users and in-
corporating their preferences in an iterative process.
 ► Our sample of interviewed men proved to be diverse 
in terms of educational level and income, which is 
another strength.
 ► The idea of behaving in a social desirable way could 
have biased cognitive interviews; to address this the 
investigators informed participants they were inter-
ested in all kind of feedback (including criticisms) 
and mainly used open- ended questions and probes.
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should be performed. Men answered PSA test should be 
done, on average, every 14.7 months and 33.9% reported 
to undergo PSA test.14 On the other hand, 65% of Portu-
guese primary care physicians reported they usually do 
PSA test for prostate cancer screening, 93% of these in 
median every 12 months.15
Decision aids are evidence- based tools which showed 
to improve the quality of the decision, increasing patient 
knowledge, making people feel clearer about their values, 
reducing decisional conflict and promoting an active 
patient role in decision making.16 17 Language can be 
a barrier to accessing relevant and high- quality health 
information and delivering appropriate healthcare.18 
Developing new decision aids in a different language can 
be time- consuming and costly.19 Consequently, adapting 
existing decision aids rather than developing new ones 
allows to benefit from previous fieldwork while avoiding 
duplication of developmental efforts and producing 
many similar material.20
Portuguese is the world’s sixth most spoken language 
and the fifth most used in the web.21 However, to date, 
there is no decision aid in European Portuguese to support 
men’s decision regarding prostate cancer screening.
Translation alone is not enough and a decision aid 
depends on the accurate assessment and understanding 
of the target population’s cultural background.22 23 Thus, 
we aimed to translate and culturally adapt an English 
language patient decision aid addressing prostate cancer 
screening to be used by Portuguese men.
MethOD
Conceptual framework for adaptation
We followed the European Centre for Disease Preven-
tion and Control’s (ECDC) five- step, stakeholder- based 
approach to adapting health communication mate-
rials.22 24
The protocol for this study was previously published.25
step 1: selection of materials and process coordinator
We searched for prostate cancer screening decision aids 
in the A to Z inventory from the Ottawa Hospital Research 
Institute (https:// decisionaid. ohri. ca/, accessed 9 
September 2018). The A to Z inventory of decision aids 
is a part of a website belonging to the patient decision 
aids research group and affiliated with the University of 
Ottawa (Canada). The inventory contains up- to- date and 
available decision aids that meet a minimal set of criteria 
in accordance with the International Patient Decision 
Aids Standards (IPDAS) collaboration. The first author 
critically appraised the decision aids using IPDAS criteria. 
Thereafter, we identified those which fulfilled most of 
the quality criteria. Of those, we selected the ‘Making 
the Best Choice’ decision aid because it was presented 
in two different formats (paper and web, link: https:// 
decisionaid. ohri. ca/ Azsumm. php? ID= 1776 - accessed 
9 September 2018). ‘Making the best choice’ is an 
English language prostate cancer screening decision aid 
which has been rigorously developed26 and extensively 
tested27–31 by a workgroup from Georgetown University 
(USA). We sought permission to translate and adapt the 
decision aid to the Portuguese population. KLT, who was 
the principal investigator of the original decision aid, is a 
co- investigator in this project.
For this study we used the print version of the decision 
aid. Briefly, the informational sections include introduc-
tory material about the prostate gland; a description of 
screening tests and possible results; information about 
treatment options, risks and adverse effects; a review of 
prostate cancer risk factors and encouragement to discuss 
screening with a physician (but without instructions to 
make an immediate appointment); a 10- item values clari-
fication tool; and resources for more information (refer-
ences and a glossary). The decision aid has been found to 
improve prostate cancer knowledge and to reduce deci-
sional conflict, with these changes remaining significant 
at the 13 months follow- up. Satisfaction was also higher 
for both formats in comparison with usual care; screening 
rates did not differ significantly among groups.28
We have reviewed the original version of the decision 
aid and associated published data in close cooperation 
with its developers to identify the core elements of the 
decision aid, namely, those concerning format and design 
features, structure, rationale and contents. SB was the 
process coordinator.
step 2: early review
Before starting the translation, the decision aid was 
reviewed by the process coordinator and by a linguistic 
expert. This early review aimed to ensure that culturally 
and technically inappropriate recommendations were 
removed. Relevant Portuguese data and materials were 
also incorporated in the decision aid. In addition, the 
linguistic expert reviewed the document in close contact 
with one of the authors of the original document and 
created a list of difficult concepts and alternative ways to 
convey the information.
The major changes after this early review included: 
(1) replacing the photos in the original decision aid with 
photos of Portuguese men; (2) replacing references to 
the American Societies/Associations’ recommendations 
(with exception to United States Preventive Services 
Task Force (USPSTF)) by the recommendations of the 
Portuguese Directorate- General for Health; (3) replacing 
American epidemiological data by Portuguese epide-
miological data; (4) in one of the testimonies there was 
this sentence: ‘That’s why I signed up for a free prostate 
screening programme’; this needed adaptation since 
it does not apply in the Portuguese healthcare service 
reality; (5) a new infographic was added, adapted from 
USPSTF.32
In addition, several years have lapsed since the original 
decision aid was developed. Therefore, a rapid review 
of clinical practice guidelines and systematic reviews of 
randomised controlled trials was performed to ensure the 
data provided were up- to- date.
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Table 1 Barriers identified by men and respective changes 
to the decision aid.
Barriers or problems 
identified by men
Changes made
(after the first 10 
interviews)
"[The title in the cover page] 
should be different in order to 
indicate it is a manual to help 
people" [D3].
We added ‘decision aid’ in 
the cover page.
Difficult term: ‘carcinoma’ Replaced with ‘cancer’
Difficult expression: 
‘anomalous results’
Replaced with ‘elevated PSA 
results’
Difficult concept: 
‘overdiagnosis’
A headline balloon was 
added with the definition 
of overdiagnosis at its first 
appearance
Asterisks at the bottom of 
the infograph—not very clear 
what they referred to
‘To be continued in the next 
page’ was added below the 
asterisks
step 3: translation and back translation
According to ECDC’s approach step 3 should include 
translation, quality check and an independent review, 
with the major aim of obtaining a conceptual equivalent 
and not a literal translation.22 Most studies describing 
the cultural adaptation of patient decision aids used 
forward and back translation by experienced, bilingual 
translators working independently and with a transla-
tion committee.20 In our study, two forward translations 
from English to Portuguese were done: by SB (native in 
Portuguese and fluent in English) and by a professional 
translator (native of Portuguese). A consensus translated 
version was obtained after resolving divergences within 
the translation committee composed by the process coor-
dinator, a linguistic expert and a team of professional 
translators. This was followed by a back translation by a 
professional translator, native speaker of English, fluent 
in Portuguese and then reviewed by KLT who was the 
coordinator of the original English decision aid. No major 
differences emerged either between the two translated 
versions or between the consensus translated version and 
the reverse translation; therefore no major changes were 
done. Afterwards, an independent expert (also familiar 
with the source language) reviewed the decision aid.
step 4: comprehension testing
This step is designed to ensure the adapted and trans-
lated decision aid is clear and understandable for its 
target end- users. Concerning this step, ECDC mentions a 
variety of approaches, including focus groups and inter-
views.22 Similarly, to several authors aiming to culturally 
adapt decision aids, we opted for individual interviews in 
which participants are asked to share their impressions 
aloud while they are going through the decision aid.20
Participants
Eligible participants were Portuguese native- speaking men 
aged 55–69 years old recruited from the local community 
(urban and suburban) of Oporto district through adver-
tisements in social media and senior universities between 
January and March 2019. A previous diagnosis of prostate 
cancer was the single exclusion criterion.
Individual semi-structured interviews
The interviews were conducted by SB, BG and DC who 
were general practice registrars, without any role in the 
participants’ healthcare. They received training and 
supervision by an expert in qualitative research (MP). 
The interviews took place at different locations in Oporto 
district, indicated by participants at their convenience, 
providing confidentiality was assured.
Participants were presented a general description of 
the decision aid and the study aims. After giving their 
written consent to participate and to have the interview 
audiorecorded, they were asked to complete a question-
naire with basic demographic data.
During the individual interviews, researchers applied 
cognitive interview methods, using think aloud, probing 
and paraphrasing techniques.33 Men were asked to share 
their impressions aloud while they were going through 
the decision aid with the purpose of identifying potential 
issues in the format and content.20
We conducted 10 interviews and updated the decision 
aid according to the interviewees' feedback, followed by a 
round of five interviews to further refine it. The barriers 
identified by men during interviews and changes made 
accordingly are presented in table 1.
Data analysis
Participants’ demographic data were analysed using 
Microsoft Excel 2016. Data obtained during the individual 
semi- structured interviews were analysed in the personal 
computers of two authors (SB, JPR), ensuring these had 
not a network connection. Each interview was given an 
alphanumeric code to omit the participant’s identity. 
After verbatim transcription of the audiofiles (SB, BG, 
DC), transcripts were read until they became familiar.
Guided by the theoretical framework, we conducted 
a thematic analysis approach to the qualitative data.34 A 
deductive approach was initially used to develop a cate-
gorisation matrix,35 in accordance with similar studies 
testing decision aids for other health- related deci-
sions.36–39 Afterwards, data were analysed following the 
principles of inductive content analysis.35 The units of 
analysis were expressions with the same core meaning. 
The first five interviews were read several times until they 
became familiar to both coders. Expressions with similar 
meaning or addressing the same issues were grouped into 
subcategories which were then put together to form the 
main categories.40 The categories (open coding) were 
then grouped into themes (axial coding). The final code-
book was established by consensus among the two coders 
(SB, JPR) and the supervising qualitative expert (MP). 
We performed thematic content analysis39 41 using Ligre 
software. Two authors (SB, JPR) independently coded 
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Table 2 Characteristics of participants and interviews
Variables n=15
Age (years),  
−x ± sd , med, 
min, max
61±4.90, 61, 55, 68
Duration of interviews 
(minutes),  
−x ± s , med, min, 
max
67.93±15.01, 66, 45, 101
Education level, n (%)   
Cannot read/write 0 (0)
Till fourth grade 1 (6.7)
Between fifth and ninth 
grade
4 (26.7)
Between 10th and 12th 
grade
7 (46.7)
College degree 3 (20.0)
Monthly income, n (%)   
Below average 5 (33.3)
On average 3 (20.0)
Above average 7 (46.7)
* 
−x : mean, med: median, min: minimum, max: maximum, n: 
absolute frequency. Monthly income reports to a Portuguese 
employee’s gross average monthly income of 924.90 in 2016. 
Source: PORDATA.
all the interviews. Divergences were solved by consensus. 
Throughout the analyses, data, codes and categories were 
discussed and regular meetings of the two coders and a 
qualitative expert took place. By including independent 
coding, peer review, confirmability checkpoints and the 
supervision by a qualitative expert throughout the process 
we aimed at improving our analysis’ reliability.42
The audiofiles were destroyed 3 months after data 
analysis.
step 5: proofreading
After the comprehension testing, proofreading was 
conducted by two native Portuguese speakers selected by 
the process coordinator, who had not read the decision 
aid before. No changes were made to the decision aid 
translation at this stage.
results
Participants
A total of 15 men agreed to be interviewed. A brief descrip-
tion of the participants is provided in table 2. Participants 
ranged in age from 55 to 68, with a mean age of 61 years. 
Interviews took on average 68 min to complete (range 
45–101 min).
themes
Five main themes are presented: informational content, 
information comprehension, sociocultural appropri-
ateness, feelings and main message, personal perspec-
tive concerning prostate cancer screening and related 
subjects. We indicate the alphanumeric code to identify 
the interview fragment cited, to ensure accurate repre-
sentation of all interviews (B1–B5, D1–D5, S1–S5). We 
have used qualitative terms to indicate the number of 
men who raised each issue: some or few (1–3), many 
(4–10) and most (>10). We reached thematic saturation 
by the tenth interview, when the same themes and similar 
comments and recommendations appeared in each inter-
view. Nevertheless, we continued in a second round of 
five interviews with the refined version of the decision 
aid, ie, after addressing the major barriers identified by 
men (table 1).
Informational content
This theme describes participants’ opinions on the way 
content is presented as well as the perceived relevance 
and interest.
Opinion on sections
Througout their review of the decision aid most men 
stated that the decision aid was easy to read and insightful, 
but some changes were suggested. In particular, many 
men reported that the introduction, facts about pros-
tate and prostate cancer and the symptoms sections 
were well written and made them more confident about 
participating in informed decision making with their 
providers. For instance, referring to the section on facts 
about the prostate and prostate cancer, one man said 
that ‘the information you provide here gives people 
the possibility of putting at stake what has been estab-
lished till now’ [S4], which may suggest the information 
in the decision aid is presented in a balanced manner 
so men can make the choice which is more congruent 
with their own preferences and values. Alluding to the 
section describing the symptoms of prostate cancer, one 
participant stated ‘It gives me peace of mind to know 
these symptoms can be associated with cancer or not’ 
[B2]. For many men the information in the treatment 
section was previously unknown, so they considered it 
important to be included in the decision aid. In addi-
tion, most men thought that ‘Beyond the basics’ and 
‘Glossary’ sections could be useful, for example, one 
man said ‘It’s never too much [information]…I would 
like to go forward and keep learning…I like this, I like 
to be up- to- date, to know a little more so I can have a 
conversation’ [S3]. Few changes were suggested in the 
aforementioned sections.
Particularly concerning the cover page, most men 
thought it was well designed, ‘transmitting ideas and 
thoughts (…) a stimulus to read [the decision aid]’ [S3]. 
One man thought the cover page design and content 
were in accordance with the subject, since ‘it shows the 
importance of men speaking to their doctors’ [D1]. 
Some added that it should be more colourful and does 
not indicate adequately what the decision aid is about. 
‘Making the best choice’…then here says ‘Prostate cancer 
screening’, it should be different in order to indicate it is 
a manual to help people [D3]. Following this suggestion 
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we added ‘decision aid’ in the cover page for the last five 
interviews and no more comments arose concerning this.
Missing contents
One man showed interest in knowing the number of 
false negatives from the PSA test, since the numbers are 
presented for false positives [S4] and another wanted to 
know more about the role of MRI [S1]. Radiotherapy 
impact on fertility [S5], prostate artery embolisation and 
robotic surgery, incontinence treatment, cancer recur-
rence and new screening tests under investigation [D3] 
were other missing themes identified by participants.
One man suggested addressing a ‘myth’ which 
according to him was spread among the male population: 
‘The absence of sexual activity causes prostate problems 
(…) it’s a myth but most talked about’ [S5].
Testimonals and values clarification method (VCM) grid
All men commented on the testimonials and values clari-
fication method grid. Many men reported their own expe-
riences after reading the two testimonials, indicating that 
they identified, at least in part, with one of the portrayed 
stories. Representative quotes are as follows.
‘Anyone reading this can see these Mr. A or Mr. B – 
and they have photos and everything – and these are two 
concrete cases (…) I’d say I think alike this 65 year old 
man [first testimonial] because, and citing ‘I’ve always 
believed it’s better to know more rather than less about 
my health’’ [S3].
‘In fact, like this man [second testimonial] … some-
times if we get an abnormal result we go home and start 
to overthink…it may be serious, we could die’ [B5].
Concerning the grid, most participants found it helpful 
and indicated their willingness to share the way they 
would answer the items in the grid, although this was not 
asked by the interviewers. Twelve men revealed an inten-
tion to undergo PSA screening from their answers to the 
values clarification grid, 2 answered against screening and 
1 did not reveal the answers out loud but had said to be 
undecided before. Some illustrative quotes are presented 
below.
‘Really useful. Because there’s a summary of most of the 
things we’ve seen here, isn’t it?’ [D4].
‘This box in the end, after all the information has 
been presented, allows people to make a more informed 
choice’ [D2].
‘They’re reducing this to “yes” or “no” to these five 
questions, but, at their heart, people probably consider 
more things (…) but it’s a grid that can help’ [D3].
Information comprehension
This theme explores how men perceive the information 
and how they are capable of translating it into their own 
words as well as the new concepts they learned from the 
decision aid.
Clarity and completeness
Most men said the decision aid was globally written in a 
clear way, easy to read and understand, concluding, for 
instance, that ‘everything here is easy to read and of easy 
comprehension’ [D2] or ‘Whoever reads this gets enlight-
ened’ [S1].
In addition, many men indirectly showed reading 
comprehension by translating the information into their 
own words. One man stopped reading the decision aid 
to comment: ‘So the prostate can grow, be inflamed or 
be associated with cancer’ [B5]. As an example, another 
participant shared his comprehension explaining ‘So, 
what they’re saying here is that the PSA test can be unreli-
able…an abnormal result may not be cancer’ [B4].
Most of the interviewees also indicated the decision aid 
was comprehensive, containing the adequate amount of 
information concerning prostate cancer screening. One 
participant said ‘I think the decision aid is very complete’ 
[B1] and another explained further that he thought it 
was ‘very elucidative. It is not boring. It goes straight to 
the point, head- on. It goes directly to themes with accu-
racy and insight’ [S5].
Figures and graphs
Figures and graphs were easily and correctly interpreted 
and turned out to help convey the information for most 
of the interviewees.
About a figure portraying the anatomy of the male 
reproductive system, participants commented: ‘By the 
way, I did not know the prostate was here’ [B5], ‘I got a 
much clearer image of the human body’ [S3] or ‘So the 
digital rectal examination is because the prostate is close 
to the intestines…now I understood’ [B2].
The infographic adapted from USPSTF and placed 
in the final decision aid (before the values clarification 
method) was a new feature of our version, not present 
in the original decision aid and most men thought it was 
useful in summing up the main information on benefits 
and harms of screening to support and informed choice . 
About the infographic one man commented it was ‘really 
interesting because it gives a percentage view’ [B1] and 
another pointed out ‘Here, 50 get erectile dysfunction, 
it’s much, I mean, surviving with these effects is serious…
one has to judge wisely in fact…’ [B4]. Most men also 
shared their surprise with the numbers presented in the 
infographic. For instance, one man summed up that 
‘Looking at this infographic we understand the results 
are not very encouraging to do the screening’ [B1] and 
another added ‘Avoiding one cancer death is not much…
the problem is that as I understood we cannot know for 
sure the cancer stage, which cancers will be letal and 
which not…but in fact looking at these number I didn’t 
know it was like this’ [B2].
New information acquired
Most men mentioned that much of the information in 
the decision aid was new to them. This included the risk 
factors for prostate cancer (many did not know men of 
African descent had higher risk), the distinction between 
prostate cancer and benign prostatic hyperplasia, the 
existence of the PSA test and its false negative and false 
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positive results, the uncertainty surrounding prostate 
cancer screening and the side effects of treatment.
Difficult concepts/expressions
‘Anomalous results’, ‘carcinoma’ and ‘overdiagnosis’ were 
each mentioned by one man as difficult to understand.
After the first round of ten interviews, we changed 
the term ‘carcinoma’ for ‘cancer’ as well as ‘anomalous 
results’ for ‘elevated PSA results’.
Although overdiagnosis was later defined in the glos-
sary, we decided to add the definition of both overdiag-
nosis and overtreatment in a headline balloon at their 
first appearance. In the last round of five interviews, no 
more difficult terms or expressions were mentioned.
Sociocultural appropriateness
Many men commented on the appropriateness of the 
decision aid to the target group of men it was developed 
for; most found it adequate and easy to understand, 
although some indicated it was too long and language 
was technical at some points. One of the interviewees 
considered ‘This was good, this information should be 
available to 90% of the population. (…) Society still hides 
a lot (…) that’s one of the reasons why it’s important to 
educate men to open themselves to talk about this with 
their doctor. (…) Some parts I found the language a little 
bit technical’ [B3]. Another one pointed out some diffi-
culties which could arise from differences in educational 
background ‘I think our population educational level is 
not that high…if you go to a rural area I’m pretty sure the 
majority of people won’t understand what’s written here 
or will only with help from a doctor’ [B1]. Considering 
the decision aid ‘rather approachable’ one of the partic-
ipants suggested it would be good to make the decision 
aid widely available ‘(…)the ideal would be a website…
and the possibility to download this’ [S3].
Feelings and main message
This section summarises the closing comments of men 
after reading the decision aid, referring both to their 
feelings and impressions as well as what they found the 
main message to be. Some acknowledged the decision 
aid could be helpful to prepare for a doctor’s appoint-
ment, as an example, one man said ‘It’s a way for people 
to clarify their doubts (…) and when going to a medical 
appointment to prepare the questions for the doctor to 
get the most information possible’ [S2].
Most men were satisfied with the decision aid and 
thought it was helpful. One man explained this way: ‘I 
liked it because there are many things in it I didn’t know 
about (…) I learned a lot’ [B2]. Another man added 
that reading the decision aid gave him ‘peace of mind…
because I thought there were more men dying of this 
cancer…’ [B1].
Few participants mentioned that they felt anxious 
after learning about the uncertainties surrounding 
prostate cancer screening. Some men mentioned that 
the decision aid’s main message was that screening was 
beneficial, although the decision aid provides informa-
tion on risks and benefits and does not encourage any 
particular decision. One man shared that to him the 
main message ‘is that people should think by themselves 
and decide what to do. Doing the best choice is doing 
a conscious choice, balancing well what to do and not’ 
[S3].
Personal perspective concerning prostate cancer screening and 
related subjects
Most men wanted to share their views, beliefs, values and 
preferences concerning prostate cancer screening and 
related subjects during the interviews. In many cases, 
participants told how their personal life experiences 
shaped their opinions.
Personal perspective on prostate cancer
Men often mentioned to associate the ideas of fear and 
death with the concept of cancer. For example, one man 
mentioned he did not know about the indolent course 
of some prostate cancers because ‘whenever I hear about 
cancer I think of death if left untreated (…) cancer means 
fear of death’ [B4]. Similarly another one said alluding to 
his personal experience ‘for me cancer is fear, because I 
was with my wife who developed cancer’ [B2].
Personal perspective on prostate cancer screening
Words like regret, prevention and anxiety appeared in 
many interviews in relation to screening. Most showed 
to be inclined to undergo prostate cancer screening. 
One man mentioned ‘I think I would do the screening 
because otherwise I couldn’t be calm…despite the side 
effects of treatment, I would be calmer if I did everything 
to prevent the worst’ [B2]. With an opposite view, other 
man said ‘I’m one of those who doesn’t agree with it 
[prostate cancer screening]. (…) And since I only knew 
about digital rectal examination, for me it was not an 
option. I’d rather trust a blood analysis (…) if PSA didn’t 
have all this uncertainty (…) I think I will stay the same’ 
[S4].
Most men commented on false negative and false posi-
tive results of PSA test reflecting on this as a negative 
misleading aspect. ‘Painful’ was the most cited word in 
relation to DRE.
One man commented on overdiagnosis showing his 
own perspective: ‘What is at stake here is overdiagnosis, 
right? And overdiagnosis perhaps is not that negative 
for me that would make me not to consider it [prostate 
cancer screening]’ [D3].
Many men recognised a practitioner control role 
in decision rather a shared decision making process 
concerning prostate cancer screening and treatment 
decisions. For example, one man explained ‘I never 
asked [PSA test], he [the doctor] used to order it for me’ 
[D4] and another one stated ‘When some test is ordered 
by a healthcare professional no one rejects it, do they? I 
don’t. This usually is not up to us to decide, we don’t have 
enough knowledge’ [S1].
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Personal perspective on prostate cancer treatment
Despite some division was evident among men concerning 
the options of active treatment and active surveillance, 
although more were in favour of the first, most men 
commented on side effects of treatment and agreed in 
connoting these negatively. Interestingly, two men used 
the expression ‘double- edged sword’ to convey the 
uncertainty surrounding prostate cancer screening and 
treatment. One of them said: ‘A person is playing with a 
double- edged sword here…if treating causes problems…
but if don’t treat, you may have problems and die’ [B3].
DIsCussIOn
summary of the main findings
The data collected from men’s interviews afforded the 
researchers the opportunity to clarify concepts and 
expand existing content of the translated decision aid. 
Most men found the decision aid to be clear, comprehen-
sive and appropriate for its target population, although 
some suggested that medical terms could be a barrier. 
No major changes were proposed by men during the 
cognitive interviews to apply to the decision aid after the 
early review and translation steps, but instead punctual 
yet valuable amends were suggested. Most participants 
revealed interest in both the figure and the infographic 
and interpreted them correctly. In addition, the majority 
of interviewees indicated that they acquired new infor-
mation from reading the decision aid and some were 
interested that additional information was added. All 
men commented on the testimonials and values clari-
fication section. Participants identified either with the 
stories or statements and shared their personal experi-
ences and preferences. Furthermore, most men revealed 
their personal preference to undergo prostate cancer 
screening.
Comparison with existing literature
This is to our knowledge the first study to conduct 
cognitive interviews with men to adapt a prostate cancer 
screening decision aid after its translation. In terms 
of themes, our results are in line with similar studies 
conducted with cognitive interviews to evaluate decision 
aids for other preference- sensitive health decisions.36–38 43 
Previous studies have shown that messages that do not 
clearly support cancer screening are seen as counterin-
tuitive and that the benefits of screening are overesti-
mated.44–46 Although participants evidenced surprise and 
interest in information on the risks of screening, for most 
these did not seem to change their intention to undergo 
screening. In fact, perception about harms is probably 
underestimated by the general population, since the 
media and even clinical trials report benefit more often 
than harms.47
Most studies with decision aids focus on measuring deci-
sion quality outcomes, but our study adds to the body of 
evidence concerning how the decision process develops 
throughout the reading of a decision aid. We noted three 
main moments which caused men to weight the harms 
and benefits: the testimonials section, the USPSTF’s 
adapted infographic and the values clarification grid. In 
that sense, we hypothesise that the infographic itself may 
have worked as an implicit values clarification method, 
since it contains the most relevant characteristics for the 
screening decision and thus men are able to consider the 
potential value on their own.48
The most recent systematic review and meta- analysis 
assessing the impact of decision aids for screening deci-
sions concluded that decision aids promote an active 
patient role in decision making.17 A qualitative content 
analysis study to evaluate women’s views on a decision aid 
for breast cancer screening using focus groups showed 
that women preferred shared decision making.49 Our 
findings differ in that most men reported a practitioner 
control role in decision making, although few have 
expressed their preference in this subject but rather 
shared their experience regarding decision making with 
their doctors and many evidenced surprise on the possi-
bility of a patient role in decision making. This may in 
part be explained by a paternalist model of consultation 
still prevailing in many situations.
strengths and limitations of this study
The researchers strongly believe that decision aids are 
helpful, and that may have influenced how we analysed 
the data. We tried to address this by discussing method-
ological decisions and themes among authors. Further-
more, social desirability bias cannot be excluded, as 
participants were aware that the interviewers were clini-
cians. To minimise this, we informed participants that we 
were interested in all kind of feedback (including criti-
cisms) and we mainly used open- ended questions and 
probes. The diversity of men’s background in terms of 
educational level and income was a strength of our conve-
nience sample. In addition, the use of cognitive inter-
views proved to be instrumental in refining the decision 
aid based on men’s feedback. This was a strength of our 
study, since the cognitive interviews allowed for alpha 
testing (usability and comprehensibility) engaging end- 
users and incorporating their preferences in an iterative 
process and thus meeting IPDAS criteria for decision 
aid development.18 Our sequential methodology with a 
second moment of data validation with participants after 
the first round of cognitive interviews is another strength.
Implications for clinical practice and research
Our findings reinforce that decision aids may play an 
important role in supporting preference- sensitive health 
decisions and this should be taken into account by 
patients, physicians and policymakers. Portuguese men 
will have access to the first decision aid about prostate 
cancer screening written in Portuguese. In addition, we 
intend to make it publicly available also in a web- based 
version. So far, there has been little research related to 
translation and cultural adaptation of decision aids. We 
have found that a systematic approach to translate and 
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culturally adapt a decision aid was feasible under limited 
resources. Our experience may be refined and replicated 
by other workgroups, thus adding to the body of existing 
decision aids in a cost- effective manner. Delivery methods 
and implementation strategies of the decision aid need to 
be further studied.
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